Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Jahn

Showing results (151-160 of 155) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 155 results.
BMC Pregnancy and Childbirth|May 7, 2026
Developing a surveillance system for HIV pre-exposure prophylaxis (PrEP) use in pregnancy in MalawiFunny Kamanga, Madeleine A Squibb, Watipa Nyangulu, et al.
The Lancet. Global Health|April 15, 2022
Isoniazid-associated pellagra during mass scale-up of tuberculosis preventive therapy: a case-control studyScott A Nabity, Kelvin Mponda, Steve Gutreuter, et al.
The Lancet. HIV|April 30, 2022
Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling studyAndrew N Phillips, Anna Bershteyn, Paul Revill, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 27, 2024
Brief Report: Self-Reported HIV-Positive Status but Subsequent HIV-Negative Test Results in Population-Based HIV Impact Assessment Survey Participants-11 Sub-Saharan African Countries, 2015-2018Naeemah Z Logan, Peter H Kilmarx, Italia Rolle, et al.
Plos One|June 26, 2023
The epidemiology of HIV population viral load in twelve sub-Saharan African countriesWolfgang Hladik, Paul Stupp, Stephen D McCracken, et al.
Pageof 16

Showing results (151-160 of 155) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 155 results.
BMC Pregnancy and Childbirth|May 7, 2026
Developing a surveillance system for HIV pre-exposure prophylaxis (PrEP) use in pregnancy in MalawiFunny Kamanga, Madeleine A Squibb, Watipa Nyangulu, et al.
The Lancet. Global Health|April 15, 2022
Isoniazid-associated pellagra during mass scale-up of tuberculosis preventive therapy: a case-control studyScott A Nabity, Kelvin Mponda, Steve Gutreuter, et al.
The Lancet. HIV|April 30, 2022
Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling studyAndrew N Phillips, Anna Bershteyn, Paul Revill, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 27, 2024
Brief Report: Self-Reported HIV-Positive Status but Subsequent HIV-Negative Test Results in Population-Based HIV Impact Assessment Survey Participants-11 Sub-Saharan African Countries, 2015-2018Naeemah Z Logan, Peter H Kilmarx, Italia Rolle, et al.
Plos One|June 26, 2023
The epidemiology of HIV population viral load in twelve sub-Saharan African countriesWolfgang Hladik, Paul Stupp, Stephen D McCracken, et al.
Pageof 16